Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57). Wright, Alex; Burden, A C Felix; Paisey, Richard B; Cull, Carole A; Holman, Rury R; , Diabetes care; 2002 Feb;25(2):330-6. PMID: 11815505Category: Sulfonylureas and Secretagogues
Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. Turner, R C; Cull, C A; Frighi, V; Holman, R RJAMA : the journal of the American Medical Association; 1999 Jun 2;281(21):2005-12. PMID: 10359389Category: Sulfonylureas and Secretagogues
UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group. Matthews, D R; Cull, C A; Stratton, I M; Holman, R R; Turner, R CDiabetic medicine : a journal of the British Diabetic Association; 1998 Apr;15(4):297-303. PMID: 9585394Category: Sulfonylureas and Secretagogues
Individual sulfonylureas and serious hypoglycemia in older people. Shorr, R I; Ray, W A; Daugherty, J R; Griffin, M RJournal of the American Geriatrics Society; 1996 Jul;44(7):751-5. PMID: 8675920Category: Sulfonylureas and Secretagogues
U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group. Diabetes; 1995 Nov;44(11):1249-58. PMID: 7589820Category: Sulfonylureas and SecretagoguesTags: prediabetesmetforminglycemic controllifestyle changesinsulin therapysulfonylureas (SUs)
Hypoglycemic activity of glyburide (glibenclamide) metabolites in humans. Rydberg, T; Jönsson, A; Røder, M; Melander, ADiabetes care; 1994 Sep;17(9):1026-30. PMID: 7988301Category: Sulfonylureas and Secretagogues